Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

U.S. approval for Raxar

Nov. 7, 1997

Roussel Uclaf reports new erythromycin antibiotics

Nov. 7, 1997

New azole antifungals from Zambon/Isagro

Nov. 7, 1997

Potent new fluoroquinolones described by Bayer

Nov. 5, 1997

Oral prodrugs of novel carbapenems prepared at Wyeth-Ayerst

Nov. 4, 1997

U.K. launch for Malarone, a potent new antimalarial combination

Nov. 3, 1997

Oxazolidinone antibacterial agents prepared at P&U

Nov. 3, 1997

Antimicrobial GE-2270 derivatives from Biosearch

Oct. 31, 1997

New oxazolidinone antibacterial agents discovered at Zeneca

Oct. 30, 1997

RiboGene and Pharmacopeia to discover antiinfective compounds

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...